Search by Drug Name or NDC

    NDC 30142-0423-41 Ibuprofen and Pseudoephedrine Hydrochloride 200; 30 mg/1; mg/1 Details

    Ibuprofen and Pseudoephedrine Hydrochloride 200; 30 mg/1; mg/1

    Ibuprofen and Pseudoephedrine Hydrochloride is a ORAL TABLET, SUGAR COATED in the HUMAN OTC DRUG category. It is labeled and distributed by The Kroger Company. The primary component is IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE.

    Product Information

    NDC 30142-0423
    Product ID 30142-423_42670fee-2881-47ec-8e69-becbd3ade181
    Associated GPIs
    GCN Sequence Number 013742
    GCN Sequence Number Description ibuprofen/pseudoephedrine HCl TABLET 200MG-30MG ORAL
    HIC3 B5G
    HIC3 Description DECONGESTANT-NSAID, COX NON-SPEC COMB.
    GCN 92250
    HICL Sequence Number 004879
    HICL Sequence Number Description IBUPROFEN/PSEUDOEPHEDRINE HCL
    Brand/Generic Generic
    Proprietary Name Ibuprofen and Pseudoephedrine Hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Ibuprofen and Pseudoephedrine Hydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, SUGAR COATED
    Route ORAL
    Active Ingredient Strength 200; 30
    Active Ingredient Units mg/1; mg/1
    Substance Name IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE
    Labeler Name The Kroger Company
    Pharmaceutical Class Adrenergic alpha-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA074567
    Listing Certified Through 2024-12-31

    Package

    NDC 30142-0423-41 (30142042341)

    NDC Package Code 30142-423-41
    Billing NDC 30142042341
    Package 1 BLISTER PACK in 1 CARTON (30142-423-41) / 40 TABLET, SUGAR COATED in 1 BLISTER PACK
    Marketing Start Date 2001-10-13
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 2c15339d-a33b-4884-87d8-a3b50903a2c8 Details

    Revised: 3/2020